ALCON FDA Approval ANDA 062339

ANDA 062339

ALCON

FDA Drug Application

Application #062339

Application Sponsors

ANDA 062339ALCON

Marketing Status

Discontinued001

Application Products

001SOLUTION/DROPS;OPHTHALMICEQ 3.5MG BASE/ML;16,250 UNITS/ML0STATROLNEOMYCIN SULFATE; POLYMYXIN B SULFATE

FDA Submissions

ORIG1AP1984-11-30
LABELING; LabelingSUPPL5AP1993-04-14
LABELING; LabelingSUPPL6AP1993-08-18
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1995-08-04

Submissions Property Types

SUPPL7Null0

CDER Filings

ALCON
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62339
            [companyName] => ALCON
            [docInserts] => ["",""]
            [products] => [{"drugName":"STATROL","activeIngredients":"NEOMYCIN SULFATE; POLYMYXIN B SULFATE","strength":"EQ 3.5MG BASE\/ML;16,250 UNITS\/ML","dosageForm":"SOLUTION\/DROPS;OPHTHALMIC","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"STATROL","submission":"NEOMYCIN SULFATE; POLYMYXIN B SULFATE","actionType":"EQ 3.5MG BASE\/ML;16,250 UNITS\/ML","submissionClassification":"SOLUTION\/DROPS;OPHTHALMIC","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.